Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 2/3 1

Status

Terminated 1Not yet recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gynecologic 6Other 2Tumor-Agnostic 1Other hematologic neoplasm 1Breast 1

Conditions

Overweight 2Obesity 2Endometrial Neoplasms 2Neoplasms 1Infertility 1Endometrial Hyperplasia 1

Interventions

Tirzepatide 5Educational Status 4Transcutaneous Electric Nerve Stimulation 2Resistance Training 2Radiotherapy 2Mouthwashes 2Methods 2Megestrol Acetate 2Early Intervention, Educational 2Counseling 2semaglutide 1naldemedine 1mirabegron 1ma zi ren wan 1exemestane 1Xylitol 1Weights and Measures 1Vitamin D 1Tablets 1Stents 1Standard of Care 1Spermine Synthase 1Specimen Handling 1Psychiatric Rehabilitation 1Progestins 1Practice Guidelines as Topic 1Population Groups 1Nutrition Assessment 1Negative-Pressure Wound Therapy 1Mindfulness 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Megestrol Acetate × Other × 90 days × Clear all
NCT05316467 2026-06-04

Weight Management Plus Megestrol Acetate in Early-stage Endometrioid Carcinoma

Fudan University

Phase 2/3 Terminated
8 enrolled
GynecologicOther

Infertility, Obesity, Endometrial Neoplasms, Overweight

NCT07462663 2026-05-13

SHAPE-ENDO

Hospital Universitari de Bellvitge

Phase 4 Not yet recruiting
82 enrolled
GynecologicOther

Endometrial Hyperplasia, Neoplasms, Obesity, Endometrial Neoplasms, Overweight

Data powered by HemOnc (CC BY 4.0) Colophon âš¡